Kelli Oswald
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- Histone Deacetylase Inhibitors Research
- DNA Repair Mechanisms
- Heat shock proteins research
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
Papers in
-
- HIV/AIDS drug development and treatment 3
- HIV/AIDS Research and Interventions 2
-
- DNA Repair Mechanisms 2
- Heat shock proteins research 2
- Protein Degradation and Inhibitors 1
- Co-authors
- Philip J. Tofilon (4 shared papers)Kevin Camphausen (4 shared papers)William Burgan (4 shared papers)Michael Cerra (3 shared papers)Jeffery S. Russell (2 shared papers)Jane B. Trepel (1 shared paper)Min-Jung Lee (1 shared paper)Hideaki Dote (1 shared paper)
- Journals
- PLoS Pathogens (1 paper)Clinical Cancer Research (1 paper)AIDS Research and Human Retroviruses (1 paper)Clinical and Vaccine Immunology (1 paper)Journal of Virology (1 paper)
- Partner nations
- United States
In The Last Decade
Kelli Oswald
8 papers receiving 616 citations
Peers
Comparison fields: 5 of 70
- Virology 104
- Molecular Biology 437
- Genetics 59
- Oncology 127
- Infectious Diseases 81
Countries citing papers authored by Kelli Oswald
This map shows the geographic impact of Kelli Oswald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli Oswald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli Oswald more than expected).
Fields of papers citing papers by Kelli Oswald
This network shows the impact of papers produced by Kelli Oswald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli Oswald. The network helps show where Kelli Oswald may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelli Oswald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 183 | |
| 2 | Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. | 2003 | 137 |
| 3 | Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization. | 2003 | 94 |
| 4 | 2004 | 81 | |
| 5 | 2017 | 66 | |
| 6 | 2016 | 34 | |
| 7 | 2014 | 31 | |
| 8 | 2018 | 6 | |
| 9 | 2025 | 0 |
About Kelli Oswald
Kelli Oswald is a scholar working on Infectious Diseases, Molecular Biology, Virology, Epidemiology and Immunology, having authored 9 papers that have together received 632 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (3 papers), HIV/AIDS Research and Interventions (2 papers), DNA Repair Mechanisms (2 papers), Herpesvirus Infections and Treatments (2 papers), Heat shock proteins research (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Virology (104 citations), Molecular Biology (437 citations), Genetics (59 citations), Oncology (127 citations) and Infectious Diseases (81 citations). Kelli Oswald has collaborated with scholars based in United States. Frequent co-authors include Philip J. Tofilon, Kevin Camphausen, William Burgan, Michael Cerra, Jeffery S. Russell, Jane B. Trepel, Min-Jung Lee, Hideaki Dote, Jeffrey D. Lifson and Melinda G. Hollingshead. Their work appears in journals such as PLoS Pathogens, Clinical Cancer Research, AIDS Research and Human Retroviruses, Clinical and Vaccine Immunology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.